ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qazi, S.
Right arrow Articles by Yamashita, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qazi, S.
Right arrow Articles by Yamashita, F

Archives of Disease in Childhood, Vol 75, 482-488, Copyright © 1996 by Archives of Disease in Childhood.


PAPERS

Dexamethasone and bacterial meningitis in Pakistan

SA Qazi, MA Khan, N Mughal, M Ahmad, B Joomro, Y Sakata, N Kuriya, T Matsuishi, KA Abbas and F Yamashita
Children's Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan.

The objective of this study was to assess, in a developing country setting, the effect of dexamethasone therapy on bacterial meningitis outcomes. A prospective double blind placebo controlled trial was conducted in 89 children aged from 2 months to 12 years suffering from bacterial meningitis. Neurological, developmental, and hearing assessments were conducted at one, four, and 12 months after discharge. Forty eight patients received dexamethasone and 41 placebo. Initial antimicrobial drugs used were ampicillin and chloramphenicol. For all patients at the time of admission the mean duration of illness was 5.7 days; 47% had had seizures and 56% had impaired consciousness. Seventeen of 89 (19%) patients died. The mortality for the dexamethasone group was 25% as compared with 12% in the group receiving placebo. Presentation to the hospital after four days of symptoms and with impaired conscious state were independent predictors of death. Of the dexamethasone group survivors, 26.5% had neurological sequelae and 42.3% had hearing impairment, whereas in the placebo group it was 24% and 30% respectively. Altered state of consciousness was a predictor of neurological sequelae. The presence of neurological sequelae and high cerebrospinal fluid protein independently predicted hearing loss. No beneficial effect of dexamethasone was observed on morbidity or mortality of this group of patients with bacterial meningitis. Dexamethasone is therefore not useful in developing countries as adjunctive treatment in patients seriously ill with bacterial meningitis, who present late for treatment and have been partially treated.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
S. McGee and J. Hirschmann
Use of Corticosteroids in Treating Infectious Diseases
Arch Intern Med, May 26, 2008; 168(10): 1034 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. van der Flier, S. P. M. Geelen, J. L. L. Kimpen, I. M. Hoepelman, and E. I. Tuomanen
Reprogramming the Host Response in Bacterial Meningitis: How Best To Improve Outcome?
Clin. Microbiol. Rev., July 1, 2003; 16(3): 415 - 429.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
K. Grimwood, P. Anderson, V. Anderson, L. Tan, and T. Nolan
Twelve year outcomes following bacterial meningitis: further evidence for persisting effects
Arch. Dis. Child., August 1, 2000; 83(2): 111 - 116.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
P. K. Coyle
Glucocorticoids in Central Nervous System Bacterial Infection
Arch Neurol, July 1, 1999; 56(7): 796 - 801.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1996 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health